Physician profile
Ami A Patel
NPI 1033179619
$549.55
in general payments reported to CMS, 2019-2025
12 companies · $28.27 in 2025
The $28.27 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.43 · 2020: $19.50 · 2021: $120 · 2022: $288 · 2023: $30.24 · 2024: $16.43 · 2025: $28.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $150.12 | 2022 | |
| Novo Nordisk INC | $124.99 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $77.67 | 2021 | |
| Braintree Laboratories, INC. | $49.82 | 2020-2021 | |
| Glaxosmithkline, LLC. | $29.76 | 2019-2024 | Arexvy, Shingrix |
| Exact Sciences Corporation | $28.27 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $19.17 | 2019 | |
| Sanofi Pasteur INC. | $17.00 | 2023 | |
| Portola Pharmaceuticals, LLC | $14.93 | 2019 | |
| Phadia US INC. | $13.24 | 2023 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.44 | 2022 | |
| Merck Sharp & Dohme LLC | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.